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ABSTRACT
The inhibiting effect of ouabain on sweat rate and sodium reabsorption is reversible
by diphenyihydantoin. The increase in sweat rate produced by diphenyihydantoin was
more marked than its effect on sodium reabsorption. These effects of diphenyihydantoin
are thought to be due to an increase in active sodium transport in secretory and duct
cells.
Cardiac glycosides such as ouabain (G-stro-
phanthin) have two distinct effects on the
heart, a positive inotropic action (an increase
in the force of contraction of the heart muscle)
and an arrhythmic action (an effect on the
electrical behavior of muscle membrane) (1, 2).
These effects are probably mediated through
two different mechanisms, the inotropie action
through mobilization of intracellular calcium
(1, 2), and the arrhythmic action through inter-
ference with membrane sodium and potassium-
activated ATPase (Nat + K-ATPase) (1, 3).
Diphenyihydantoin sodium (DPH) suppresses
both supraventricular and ventricular arrhyth-
mias, particularly those resulting from digi-
talis toxicity without inhibiting the inotropic
action of the cardiac glycoside (1, 2, 4, 5).
DPH also stabilizes membranes and has an
activating effect on the sodium pump (6).
We previously studied the effect of ouabain
(a specific inhibitor of Na + K-ATPase) on
the human eccrine sweat gland and postulated
that this drug inhibits active transport of
sodium by the secretory and ductal cells, thus
implying the presence of Na* + K-ATPase-
linked active transport in both these cells (7).
If the arrhythmic effect of cardiac glycosides
is mediated through inhibition of Na + K-
ATPase in the cell membrane of the heart mus-
cle and is reversed or prevented by DPH,
then ouabain-induced inhibition of eccrine sweat
gland function should also be reversible with
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DPH. In this study, the effects of ouabain
and DPH alone and ouabain and DPH in com-
bination on sweat sodium secretion and reab-
sorption, potassium excretion and sweat rate
were compared.
MATERIALS AND METHODS
Twelve healthy men ages 21 to 40 were used as
subjects. Four injection solutions were prepared
immediately before each experiment, ouabain in
Ringer's solution (5 X 10°M), ouabain (5 X
10M) plus DPH (5 X 108M) in Ringer's solution,
DPH (5 X 10°M) in Ringer's solution and
Ringer's solution alone. All studies were conducted
using the skin of the upper back. The four sites
used are depicted in Figure 1.
Experiment I. In 3 subjects, one ml of DPH in
Ringer's solution was injected intradermally into
Site I two hours and one hour before sweating.
Ringer's solution alone was injected at the same
time into Site II.
Experiment II. In 12 subjects, 2.5 hours before
sweating, one ml of DPH in Ringer's solution
was injected intradermally into Site I and Ringer's
solution alone into Sites II and III. Two hours and
one hour before sweating, one ml of ouabain (5 X
1O-6M) plus DPH was injected into Site I, oua-
bain (5 X 10-5M) into Site II and Ringer's solu-
tion alone into Site III. The times of injection and
the solutions used in this experiment have been
tabulated in Table I. In 4 of the 12 subjects Site
IV was injected with one ml of Ringer's solution
2.5 hours before sweating and one ml of ouabain
in Ringer's solution (1.7 X 10°M) two hours and
one hour before sweating.
Immediately before sweating the test sites were
gently cleansed with soap and water, rinsed with
ion-free distilled water and air dried. Aluminum
chambers with an internal diameter of 2.4 cm were
secured to the skin with Weldwood Contact Ce-
ment. The subjects, wearing swimming trunks,
entered an environmental chamber (40 C initially
to 460 C, 80% RH). Two Whatman 542 filter
papers, 2.4 em in diameter, were removed from
pre-weighed plastic bottles and introduced into the
chamber and sealed at time zero. The filter papers
were collected, replaced in their weighing bottle
283
284 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
and fresh, pre-weighed filter papers inserted every
5 minutes after an initial 10 minute collection pe-
riod. Ten collections were taken from each site in
all subjects. By altering the temperature of the
environmental room and the strenuousness of ex-
ercise on a treadmill, varying sweat rates were ob-
tained. An attempt was made to induce a maxi-
mum rate of sweating at the time of the last sweat
collection. The subjects were allowed water ad lib
during the experiment. Sweat volumes were deter-
mined by weight differences of the filter papers.
The filter papers were then eluted with 10 ml of
ion-free distilled water and the sodium concentra-
tions determined with a Baird-Atomic flame pho-
tometer. Suitable blanks were used for each sub-
ject. For each individual, sodium concentrations
were plotted against sweat rates.
RESULTS
As shown in Figure 2, the intradermal in-
jection of DPH alone had no effect on sweat
rate or sodium concentration of the sweat.
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Fio. 2. Sodium concentration vs. sweat rate
after the injection of Ringer's solution or diphenyl-
hydantoin (DPH). No differences can be detected.
Table II lists the mean sweat rates obtained
after the injection of (A) ouabain (5 )< 1O°M),
(B) ouabain (1.7 X 10°M), (C) DPH (5 X
103M) + ouabain (5 X 10M), and (D)
Ringer's solution. The highest mean sweat
rates occurred after the injection of Ringer's
solution. The higher concentration of ouabain,
5 x 10M, reduced the mean sweat rate in all
12 subjects to an average of 38% of those ob-
tained after Ringer's solution was injected. The
lower concentration of ouabain, 1.7 X 106M,
reduced the mean sweat rate in the 4 subjects
tested to an average of 81% of the controls.
The addition of DPH to the higher concen-
tration of ouabain significantly counteracted
the effect of the ouabain since mean sweat
rates under these conditions averaged 100% of
the control values (mean of 1—4). This effect is
shown graphically in Figure 3.
The protocol of Experiment II
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Foe. 1. The four sites on the upper back used in
this study.
TABLE I
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TABLE II
Mean sweat rate (mi/minim2)
Subject (A)ouabain
X 10—6 M
(B)
ouabain
1.7 X 106 M
(C)
DPH (5 X
10' M) +
ouabain5 X 10M
(D)
Ringer's
solution
(C)
—(D) %
(A)
—(D) %
(B)
—(D) %
1. V.V.
2. N.G.
3. M.M.
4. A.H.
5. J.B.
6. G.B.
7. W.S.
8. S.T.
9. K.J.
10. C.O.
11. T.D.
12. 11.11.
4.86
6.25
11.85
11.47
4.47
5.13
3.23
1.93
6.52
2.45
7 88
4.08
13.20
9.95
18.75
9.30
13.99
12.66
17.62
14.56
11.20
9.59
8.41
7.87
10.01
14.13
13 40
9.43
15.60
10.61
23.44
12.53
15.41
17.65
17.60
15.71
16.13
13.00
15.43
15.39
89.7
119.3
75.2
116.2
72.7
54.3
47.8
50.1
62.1
108.7
86.8
61.3
31.2
58.9
50.6
91.5
29.0
29.1
18.4
12.3
38.7
18.8
51.1
26.5
84.6
93.8
80.0
63.9
Mean S.E. (1—12)
Mean S.E. (1—4)
5.84
0.89
8.61
1.55
12.80
1.87
11.91
0.81
14.71
15.71
0.88
15.55
78.68
7.05
100.1
38.01
6.12
58.1 80.6
Figure 4 shows plots of sodium concentra-
tions against sweat rates for the 12 subjects.
Ouabain (5 X 10-°M) was associated with the
highest sodium concentration and Ringer's solu-
tion the lowest. The addition of DPH to oua-
bain (5 X 10AM) reduced the sodium con-
centration to a level midway between those of
ouabain alone and Ringer's solution in most
cases.
In four subjects, sodium concentrations were
compared between the lower concentration of
ouabain (1.7 x 10'M) and the higher con-
centration of ouabain (5 x 106M) plus IJPH
(5 x 103M) (Figure 5). The latter was asso-
ciated with slightly lower sodium concentra-
tion than the former, although there is some
overlapping of the data.
The effect of ouabain on potassium excre-
tion was partially counteracted by DPII i 6
of the 12 subjects. A representative example
is shown in Figure 6. Ouabain alone produced
a slight increase in the rates of potassium ex-
cretion in most subjects. With the addition of
DPH the rates of potassium excretion were
approximately midway between the results
obtained with ouabain alone and Ringer's solu-
tion.
DISCUSSION
In the present study the inhibiting effect of
ouabain on sweat rate and sodium reabsorp-
tion has been shown to be reversible by the
FIG. 3. The effect of ouabain alone and ouabain
plus diphenyihydantoin (DPH) on mean sweat
rates. Mean sweat rate after Ringer's solution is
given as 100%. Ouabain (5 X 10M) markedly re-
duces the sweat rate. Ouabain (1.7 X 10°M) pro-
duces a slight reduction in sweat rate. DPH re-
verses the effect of the higher concentration of
ouabain.
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Fic. 4. Sweat sodium concentration vs. sweat rate. Ouabain (5 x 108M) decreases sweat
rate and increases sodium concentration. The addition of DPH partially reverses these
effects.
administration of diphenyihydantoin (DPH).
The increase in sweat rate produced by DPH
was more marked than its effect on sodium
reabsorption. These effects of DPH were equiv-
alent to reducing the concentration of ouabain
by about one-third and are presumably due to
an increase in active sodium transport in both
the secretory and ductal cells. These effects
seem analogous to the effect of DPH in reduc-
ing digitalis-induced arrhythmia in the canine
heart. Helfant et al. (1) have shown that the
prophylactic administration of DPH increased
the dose of digitalis necessary to produce
toxicity by 72% to 224% without inhibiting its
inotropic action, implying that the arrhyth-
mic and inotropic actions of cardiac glycosides
are disassociatable. Although the present stud-
ies produce no direct evidence to support this
implication, the similarity between the effect of
DPH on the ouabain-induced reduction in ac-
tive sodium transport by the ecerine sweat gland
and on digitalis-induced arrhythmia suggests
that both are produced by inhibition of Na +
K3-ATPase activity. Further evidence in favor
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of this concept is provided by the finding that
toxic doses of cardiac glycosides consistently
lower the intracellular concentration of potas-
sium while raising that of sodium in a variety
of cells, including cardiac muscle (3). This ef-
fect is generally believed to result from inter-
ference with active transport at the cell mem-
brane and it, too, can be reversed by DPH
(8). In this study, too, the slightly higher po-
tassium concentrations in sweat (probably due
to the leakage of intracellular K) after treat-
ment with ouabain, were partially reversed by
the addition of DPII, thus suggesting a simi-
larity in the effect of DPH on ouabain in both
sweat glands and cardiac muscle.
The mechanism of the action of DPH on
cell membranes remains unsettled although
most available evidence indicates that DPII
stimulates the sodium pump, or more specifi-
cally, Na + K-ATPase activity (9). On the
other hand, Ramson and Pincus (10) re-
ported that Na + K-ATPase activity derived
from microsomal fractions of rat and guinea
pig cerebral cortex was slightly but consistently
inhibited by DPH and that the inhibiting ef-
fects of DPII and ouabain were additive. These
I I I
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0DPH5x1O3M+ M.M.
0uabain 5xI0M
• •o 0
• o0
.0
I I I I I
¶ I
5 0 ¶5 20 05 30
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Fia. 6. Ouabain (5 X 10°M) increases the rate
of potassium excretion. This effect is partially re-
versed by DPH.
results are in conflict with our data which show
no evidence of DPH inhibition of sodium
transport in the sweat gland. DPH, in fact,
partially reverses the inhibitory effect of oua-
ham. Although we cannot entirely explain this
discrepancy, it may be that the Na + K-
ATPase of the plasma membrane and the
microsomal fraction differ since there is no
evidence that the endoplasmic reticulum partici-
pates in the active transport of cations in the
.
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FIG. 5. Sweat sodium concentration vs. sweat rate. When DPH is added to ouabain(5 X 10°M) the results overlap with those produced by ouabain, one-third as concentrated
(1.7 X 106M).
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same way as the plasma membrane (11). An-
other possibility is that Na + K-ATPases
are identical regardless of their origin and
that the microsomal fraction of Ramson and
Pincus (10) was contaminated by plasma mem-
brane as occurred in the studies of Wallach
et al. (8) using Ehrlich ascites tumor cells. It
appears more likely that DPH acts as a com-
petitive inhibitor of cardiac glycosides for mem-
brane Na + K-ATPase, DPH being a much
weaker inhibitor than ouabain. This explana-
tion seems consistent with our finding (un-
published data) that prior injection of DPH
was more effective in reversing ouabain-induced
inhibition of sweat gland function than in-
jection of DPH after pre-treatment with oua-
bain. However, this hypothesis does not ac-
count for other membrane-stabilizing properties
of DPH such as the prevention of an increase
in intracellular sodium after electroshock-in-
duced seizures or in hyponatremia (9).
REFERENCES
1. Helfant, R. H., Scherlag, B. J. and Damato,
A. N.: Protection from digitalis toxicity with
the prophylactic use of diphenyihydantion
sodium. Circulation, 36: 119, 1967.
2. Mosey, L. and Tyler, A.: The effect of diphe-
nyihydantoin sodium (Dilantin) procaine
hydrochloride, and quinidine hydrochloride
upon ouabain-induced ventricular tachy-
cardia in unanesthetized dogs. Circulation,
10: 65, 1954.
3. Lyon, A. F. and DeGraff, A. C.: Reappraisal
of digitalis, Part I. Digitalis action at the
cellular level. Amer. Heart J., 72: 414, 1966.
4. Lang, I., Bernstein, H., Barbieri, F. F., Gold,
H. and Corday, E.: Digitalis toxicity: Treat-
ment with diphenylhydantoin. Arch. Intern.
Med., 116: 573, 1965.5. Conn, R. D., Kennedy, J. W., and Black-
man, 3. R.: The hemodynamic effect of di-
phenylhydantoin. Amer. Heart J., 73: 500,
1967.
6. Goodman, L. S. and Gilman, A.: p. 219, The
Pharmacological Basis of Therapeutics, 3rd
ed. Macmillan, New York, 1965.
7. Sato, K., Taylor, 3. R. and Dobson, R. L.:
Effect of ouabain on ecerine sweat gland
function. Submitted to J. Invest. Derm. Oct.
1989.
8. Wallach, B. F. H. and Kamert, V. B.: Plasma
and cytoplasmic membrane fragments from
Ehrlich ascites carcinoma. Proc. Nat. Acad.
Sci., 52: 721, 1964.
9. Woodbury, D. M.: Effect of diphenylhydan-
tom on electrolytes and radio-sodium turn-
over in brain and other tissues of normal,
hyponatremic and postictal rats. J. Pharm.
Exp. Ther., 115: 74, 1955.
10. Ramson, M. D. and Pincus, J. H.: The effect
of diphenylhydantoin on sodium, potassium,
magnesium-activated adenosine triphospha-
tase in microsomal fractions of rat and guinea
pig brain and on whole homogenates of hu-
man brain. Biochem. Pharmac., 17: 573, 1968,
11. Katz, A. I. and Epstein, F. H.: Physiologic
role of sodium-potassium-activated adeno-
sine triphosphatase in the transport of cat-
ions across biological membranes. New Eng.
J. Med., 278: 253, 1968.
